Title: Minogiannis, P., et al., Hydroxyzine inhibits neurogenic bladder mast cell activation. Int J Immunopharmacol, 1998. 20(10): p. 553-63.
1808202-93-8
13073-96-6
163837-48-7
164726-80-1
83881-52-1
109806-71-5
238089-02-6 | E-Ospemifene | AA01CBUI
68648-93-1 | 1,2-Benzenedicarboxylic Acid, mixed decyl and hexyl and octyl diesters (1:1:1 Mixture of B185420 and D228455 and D228460) | AA01CBXE
92962-89-5 | 2(1H)-Quinolinone, 3,4-dihydro-7-(phenylmethoxy)- | AA01CC1A
1477495-19-4 | Bis(1,3-dichloro-2-propyl) Phosphate-d10 | AA01CC44
1189734-21-1 | rac Methotrimeprazine-d6 Hydrochloride | AA01CC7H | MFCD28899380
1005452-36-7 | 1(E)-Butenylboronic Acid | AA01CCAM | MFCD09840136
1391053-28-3 | rac 5-Carboxy Desisopropyl Tolterodine Methyl Ester | AA01CCE5
1286538-12-2 | Sulfamonomethoxine-d4 | AA01CCHF | MFCD28899431
15555-35-8 | Triethyloxonium Tetrachloroferrate(III) | AA01CCLC
874297-89-9 | 4-Methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxamide | AA01CM8C | MFCD28805779